Cargando…

A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic

Detalles Bibliográficos
Autores principales: Kanjilal, Sanjat, Tang, Yi-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983603/
https://www.ncbi.nlm.nih.gov/pubmed/35636829
http://dx.doi.org/10.1016/j.cll.2022.04.001
_version_ 1784681996804423680
author Kanjilal, Sanjat
Tang, Yi-Wei
author_facet Kanjilal, Sanjat
Tang, Yi-Wei
author_sort Kanjilal, Sanjat
collection PubMed
description
format Online
Article
Text
id pubmed-8983603
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89836032022-04-06 A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic Kanjilal, Sanjat Tang, Yi-Wei Clin Lab Med Preface Published by Elsevier Inc. 2022-06 2022-04-06 /pmc/articles/PMC8983603/ /pubmed/35636829 http://dx.doi.org/10.1016/j.cll.2022.04.001 Text en © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Preface
Kanjilal, Sanjat
Tang, Yi-Wei
A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic
title A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic
title_full A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic
title_fullStr A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic
title_full_unstemmed A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic
title_short A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic
title_sort tale of trial and triumph: molecular diagnostics for severe acute respiratory coronavirus 2 over the first two years of the coronavirus disease 2019 pandemic
topic Preface
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983603/
https://www.ncbi.nlm.nih.gov/pubmed/35636829
http://dx.doi.org/10.1016/j.cll.2022.04.001
work_keys_str_mv AT kanjilalsanjat ataleoftrialandtriumphmoleculardiagnosticsforsevereacuterespiratorycoronavirus2overthefirsttwoyearsofthecoronavirusdisease2019pandemic
AT tangyiwei ataleoftrialandtriumphmoleculardiagnosticsforsevereacuterespiratorycoronavirus2overthefirsttwoyearsofthecoronavirusdisease2019pandemic
AT kanjilalsanjat taleoftrialandtriumphmoleculardiagnosticsforsevereacuterespiratorycoronavirus2overthefirsttwoyearsofthecoronavirusdisease2019pandemic
AT tangyiwei taleoftrialandtriumphmoleculardiagnosticsforsevereacuterespiratorycoronavirus2overthefirsttwoyearsofthecoronavirusdisease2019pandemic